Research Peptides
RESEARCH USE ONLY
Research Peptides
RESEARCH USE ONLY
| Ingredients | Short-acting GHRH analog (CJC-1295 no DAC) — tetrasubstituted GRF(1-29) analog |
|---|---|
| Storage | Lyophilized powder: store refrigerated at 2–8°C, protected from light and moisture; after reconstitution, store at 2–8°C and use within 48 hours |
| Shelf life | 24 months (original lyophilized powder) |
| SKU | Content - Spec | Pack | Price | Stock |
|---|---|---|---|---|
| CND02 | 2mg | 10 vials | $39.00 | In stock |
| CND05 | 5mg | 10 vials | $79.00 | In stock |
| CND10 | 10mg | 10 vials | $119.00 | In stock |
Research reagents are for laboratory and in-vitro research only. Not for human use.
Research reagents are not supplied as medicines and must not be used for diagnosis, treatment, prevention, clinical procedures or self-medication. Product information must not be used as administration or dosing guidance.
For accessories and consumables, follow their own specifications and documented intended use.
CJC-1295 without DAC (Modified GRF 1-29) is a synthetic GHRH analog consisting of the first 29 amino acids of native GHRH with four amino acid substitutions for improved stability. With a short half-life of approximately 30 minutes, it stimulates pulsatile growth hormone release that closely mimics the body’s natural secretory pattern, unlike the long-acting DAC version. It is highly valued for its strong synergistic effect when stacked with GHRPs such as Ipamorelin or GHRP-2, producing significantly amplified GH and IGF-1 levels (30-60% increase) while preserving natural feedback regulation. Research highlights benefits in body composition, sleep quality, recovery, and anti-aging without desensitization over extended use. It is generally well-tolerated, with only mild and transient side effects such as flushing, headache, or injection site reactions.
Promotes muscle growth; accelerates fat burning; improves sleep quality; enhances bone density; boosts physical recovery; may improve skin elasticity
Typically injected 2–3 times per week, 100–200 mcg (0.1–0.2 mg) per dose, divided between morning and evening; reconstitute with sterile water or bacteriostatic water; administration on an empty stomach or before bedtime is recommended; cycle length 4–8 weeks, preferably combined with an appropriate training and nutrition regimen.
Individuals training for muscle gain; those seeking fat loss and body shaping; middle-aged and older adults with low growth hormone levels; athletes requiring enhanced recovery